These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 723447)

  • 1. Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum.
    Garau L; Govoni S; Stefanini E; Trabucchi M; Spano PF
    Life Sci; 1978 Oct; 23(17-18):1745-50. PubMed ID: 723447
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics.
    Memo M; Battaini F; Spano PF; Trabucchi M
    Acta Psychiatr Scand; 1981 Apr; 63(4):314-24. PubMed ID: 7315480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens.
    Govoni S; Lucchi L; Missale C; Memo M; Spano PF; Trabucchi M
    Brain Res; 1986 Aug; 381(1):138-42. PubMed ID: 3756492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of membrane proteins in response to persistent stimulation of adenylate cyclase-linked dopamine receptors in slices of striatum.
    Memo M; Hanbauer I
    Neuropharmacology; 1984 Apr; 23(4):449-55. PubMed ID: 6728131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulpiride isomers exhibit reversed stereospecificity for D-1 and D-2 dopamine receptors in the CNS.
    Leff SE; Chen A; Creese I
    Neuropharmacology; 1984 May; 23(5):589-90. PubMed ID: 6738827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging process affects a single class of dopamine receptors.
    Memo M; Lucchi L; Spano PF; Trabucchi M
    Brain Res; 1980 Dec; 202(2):488-92. PubMed ID: 7437912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary.
    Jaber M; Tison F; Fournier MC; Bloch B
    Brain Res Mol Brain Res; 1994 Apr; 23(1-2):14-20. PubMed ID: 7518029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists.
    Roufogalis BD; Thornton M; Wade DN
    Life Sci; 1976 Sep; 19(6):927-34. PubMed ID: 966971
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of sulpiride-displaceable 3H-YM-09151-2 binding sites in rat frontal cortex and the effects of subchronic treatment with haloperidol on cortical D-2 dopamine receptors.
    Kazawa T; Mikuni M; Higuchi T; Arai I; Takahashi K; Yamauchi T
    Life Sci; 1990; 47(6):531-7. PubMed ID: 2402179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulpiride: a study of the effects on dopamine receptors in rat neostriatum and limbic forebrain.
    Trabucchi M; Longoni R; Fresia P; Spano PF
    Life Sci; 1975 Nov; 17(10):1551-6. PubMed ID: 173950
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanine nucleotides distinguish between two dopamine receptors.
    Creese I; Usdin T; Snyder SH
    Nature; 1979 Apr; 278(5704):577-8. PubMed ID: 431724
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1993 Feb; 232(1):1-6. PubMed ID: 8458389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-dependent regulator involvement in the dopamine receptors supersensitivity.
    Lucchelli A
    Pharmacol Res Commun; 1980 Jul; 12(7):709-17. PubMed ID: 7190711
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors.
    Trabucchi M; Memo M; Battaini F; Reggiani A; Spano PF
    Adv Biochem Psychopharmacol; 1980; 24():275-81. PubMed ID: 7405667
    [No Abstract]   [Full Text] [Related]  

  • 17. Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months.
    Clow A; Jenner P; Theodorou A; Marsden CD
    Nature; 1979 Mar; 278(5699):59-61. PubMed ID: 570253
    [No Abstract]   [Full Text] [Related]  

  • 18. Ontogenesis of dopamine receptor binding in the corpus striatum of the rat.
    Pardo JV; Creese I; Burt DR; Snyder SH
    Brain Res; 1977 Apr; 125(2):376-82. PubMed ID: 851885
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
    Jenner P; Rupniak NM; Hall MD; Dyer R; Leigh N; Marsden CD
    Eur J Pharmacol; 1981 Nov; 76(1):31-6. PubMed ID: 6119220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats.
    Pycock CJ; Kerwin RW; Carter CJ
    Nature; 1980 Jul; 286(5768):74-6. PubMed ID: 7393327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.